KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - NetLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecuritiesSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvb Financial (CVBF) Securities - Tradable (2017 - 2025)

Cvb Financial's Securities - Tradable history spans 9 years, with the latest figure at $2.7 billion for Q4 2025.

  • For Q4 2025, Securities - Tradable rose 5.54% year-over-year to $2.7 billion; the TTM value through Dec 2025 reached $2.7 billion, up 5.54%, while the annual FY2025 figure was $2.7 billion, 5.54% up from the prior year.
  • Securities - Tradable reached $2.7 billion in Q4 2025 per CVBF's latest filing, up from $2.6 billion in the prior quarter.
  • In the past five years, Securities - Tradable ranged from a high of $3.6 billion in Q1 2022 to a low of $2.5 billion in Q3 2024.
  • Average Securities - Tradable over 5 years is $2.9 billion, with a median of $2.9 billion recorded in 2021.
  • Peak YoY movement for Securities - Tradable: surged 74.93% in 2021, then decreased 15.39% in 2023.
  • A 5-year view of Securities - Tradable shows it stood at $3.2 billion in 2021, then increased by 2.24% to $3.3 billion in 2022, then dropped by 9.19% to $3.0 billion in 2023, then fell by 14.01% to $2.5 billion in 2024, then rose by 5.54% to $2.7 billion in 2025.
  • Per Business Quant, the three most recent readings for CVBF's Securities - Tradable are $2.7 billion (Q4 2025), $2.6 billion (Q3 2025), and $2.5 billion (Q2 2025).